Vaccination in Individuals with Multiple Sclerosis - Part I

dc.contributor.authorCinar, Bilge Piri
dc.contributor.authorTuncer, Asli
dc.contributor.authorBilge, Nuray
dc.contributor.authorBunul, Sena Destan
dc.contributor.authorGozubatik Celik, Rabia Gokcen
dc.contributor.authorCiftci, Eda Derle
dc.contributor.authorGenc, Gencer
dc.contributor.authorKaraman, Bedriye
dc.contributor.authorKilic, Ahmet Kasim
dc.contributor.authorSariteke, Alp
dc.contributor.authorSeferoglu, Meral
dc.contributor.authorTiftikcioglu, Bedile Irem
dc.contributor.authorTunc, Abdulkadir
dc.contributor.authorUncu, Gulgun
dc.contributor.authorYavas, Irfan
dc.contributor.authorYetkin, Mehmet Fatih
dc.contributor.authorEfendi, Husnu
dc.contributor.authorSiva, Aksel
dc.contributor.orcID0000-0001-6900-4702en_US
dc.date.accessioned2024-09-11T13:08:18Z
dc.date.available2024-09-11T13:08:18Z
dc.date.issued2023
dc.description.abstractMultiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions should be made by considering the disease process and the drugs used by the patient. Since vaccination can be performed at every stage of life, from childhood to adulthood, immune system activity, except where it is characteristic of the vaccine, should be reviewed in patients with MS. In this review, the applications of different vaccines in individuals with MS are discussed in two separate sections.en_US
dc.identifier.eissn1309-2545en_US
dc.identifier.endpage11en_US
dc.identifier.issn1301-062Xen_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85156204478en_US
dc.identifier.startpage2en_US
dc.identifier.urihttps://tjn.org.tr/full-text/50/eng
dc.identifier.urihttp://hdl.handle.net/11727/12203
dc.identifier.volume29en_US
dc.identifier.wos001050888800002en_US
dc.language.isoengen_US
dc.relation.isversionof10.4274/tnd.2023.62592en_US
dc.relation.journalTURKISH JOURNAL OF NEUROLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMultiple sclerosisen_US
dc.subjectvaccinationen_US
dc.subjectsafetyen_US
dc.titleVaccination in Individuals with Multiple Sclerosis - Part Ien_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
eng (2).pdf
Size:
169.87 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: